Arvee Laboratories (India) Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Shalin Patel
Chief executive officer
₹3.7m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.9yrs |
| CEO ownership | n/a |
| Management average tenure | 7.5yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
Arvee Laboratories (India) Ltd.'s (NSE:ARVEE) Popularity With Investors Under Threat As Stock Sinks 28%
Jan 12
Arvee Laboratories (India) Ltd.'s (NSE:ARVEE) Popularity With Investors Under Threat As Stock Sinks 25%
Nov 21Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Might Deserve Your Attention Today
Aug 08Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Is Well Worth Watching
Apr 13Do Arvee Laboratories (India)'s (NSE:ARVEE) Earnings Warrant Your Attention?
Dec 22We Ran A Stock Scan For Earnings Growth And Arvee Laboratories (India) (NSE:ARVEE) Passed With Ease
Sep 16Subdued Growth No Barrier To Arvee Laboratories (India) Ltd.'s (NSE:ARVEE) Price
Aug 13Calculating The Intrinsic Value Of Arvee Laboratories (India) Ltd. (NSE:ARVEE)
Apr 19CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | n/a | n/a | ₹14m |
| Mar 31 2025 | ₹4m | n/a | ₹21m |
| Dec 31 2024 | n/a | n/a | ₹22m |
| Sep 30 2024 | n/a | n/a | ₹23m |
| Jun 30 2024 | n/a | n/a | ₹15m |
| Mar 31 2024 | ₹4m | n/a | ₹11m |
| Dec 31 2023 | n/a | n/a | ₹9m |
| Sep 30 2023 | n/a | n/a | ₹16m |
| Jun 30 2023 | n/a | n/a | ₹35m |
| Mar 31 2023 | ₹4m | n/a | ₹41m |
| Dec 31 2022 | n/a | n/a | ₹49m |
| Sep 30 2022 | n/a | n/a | ₹45m |
| Jun 30 2022 | n/a | n/a | ₹32m |
| Mar 31 2022 | ₹4m | n/a | ₹26m |
| Dec 31 2021 | n/a | n/a | ₹22m |
| Sep 30 2021 | n/a | n/a | ₹32m |
| Jun 30 2021 | n/a | n/a | ₹27m |
| Mar 31 2021 | ₹4m | n/a | ₹27m |
| Dec 31 2020 | n/a | n/a | ₹28m |
| Sep 30 2020 | n/a | n/a | ₹17m |
| Jun 30 2020 | n/a | n/a | ₹21m |
| Mar 31 2020 | ₹1m | ₹1m | ₹23m |
| Dec 31 2019 | n/a | n/a | ₹25m |
| Sep 30 2019 | n/a | n/a | ₹27m |
| Jun 30 2019 | n/a | n/a | ₹25m |
| Mar 31 2019 | ₹1m | ₹1m | ₹23m |
Compensation vs Market: Shalin's total compensation ($USD41.92K) is about average for companies of similar size in the Indian market ($USD46.25K).
Compensation vs Earnings: Shalin's compensation has been consistent with company performance over the past year.
CEO
Shalin Patel (47 yo)
Mr. Shalin Sudhakarbhai Patel serves as the Chairman and Managing Director of Arvee Laboratories (India) Ltd. Mr. Patel has been a Non-Executive Independent Director at Shree Rama Multi-Tech Ltd. since Feb...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | 7.9yrs | ₹3.71m | no data | |
| CFO & Additional Director | 7.5yrs | ₹1.45m | 0.036% ₹ 639.2k | |
| Company Secretary & Compliance Officer | 6.8yrs | ₹120.00k | no data | |
| Whole-Time Director | no data | ₹3.71m | no data |
Experienced Management: ARVEE's management team is seasoned and experienced (7.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & MD | no data | ₹3.71m | no data | |
| CFO & Additional Director | less than a year | ₹1.45m | 0.036% ₹ 639.2k | |
| Whole-Time Director | 13.8yrs | ₹3.71m | no data | |
| Independent Director | 4.1yrs | ₹70.00k | no data | |
| Non-Executive Independent Director | 4.8yrs | ₹60.00k | no data | |
| Independent Additional Director | 3.5yrs | ₹70.00k | no data | |
| Additional Director | 1.4yrs | no data | no data |
Experienced Board: ARVEE's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/06 12:35 |
| End of Day Share Price | 2025/11/06 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Arvee Laboratories (India) Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.